INTRODUCTION
Vogt-Koyanagi-Harada (VKH) disease is considered a bilateral, granulomatous panuveitis associated with central nervous system, auditory, and integumentary manifestations. It initially manifests with prodromal symptoms similar to aseptic meningitis, followed by posterior uveitis with exudative retinal detachments and disc hyperemia (1) . VKH disease is thought to be a T-cell-mediated autoimmune process directed against one or more antigenic components of melanocytes, a cell shared by the involved regions (2) . The disease occurs more frequently in pigmented groups, it is likely that certain ethnic groups have genetic backgrounds that predispose them to VKH disease. Specific human leucocyte antigen (HLA) types have been reported to be associated with the disease. Findings from different parts of the world indicate that there is an association between class II, subtype DR4 HLA and VKH disease, especially the HLA-DRB1 * 0405 allele (3) . The precise cause of the disease is uncertain, but T-lymphocytemediated autoimmunity directed against melanocytes is likely to play an important role (4) . There are no specific diagnostic tests for VKH disease. At present, the diagnosis is usually made based on the clinical findings of prodromal CNS findings followed by a bilateral exudative posterior uveitis (5) . In addition the disease could have ocular and extraocular symptoms, only extraocular or only ocular symptoms.
The typical treatment for VKH disease is high-dose corticosteroid the- ABSTRACT rapy followed by a slow tapering of the drug over 3 to 6 months. Patients who are intolerant to or with disease that is resistant to corticosteroid therapy may be treated with immunosuppressive drug therapy to minimize complications and to improve visual prognosis (6) . Intravitreal triamcinolone acetonide may provide short-term improvement in visual acuity and resolution of serous retinal detachments in patients with VKH disease (7) . The first attempt to establish diagnostic criteria for VKH disease took place in 1978 at the Annual Meeting of the American Uveitis Society (8) . Because the sequential development of these findings often makes prospective studies unfeasible, the diagnostic criteria were revised by the First International Workshop on VKH disease in 1999 (9) (Figure 1 ) (9) . The new criteria take into account the multisystemic nature of VKH disease, with allowance for the different ocular findings that are present in the early and late stages of the disease (3) . In the present study the authors reviewed charts of patients with a previous diagnosis of Vogt-Koyanagi-Harada disease assessing the reviewed diagnostic criteria, to check the applicability of the revised criteria in a Brazilian VKH disease population.
METHODS
Medical charts of 140 patients with a diagnosis of VKH disease, from the Uveitis Sector of the Federal University of Sao Paulo (UNIFESP), were revised and classified according to the 2001 revised diagnostic criteria (Figure 1 ) (9) . A questionnaire based on the "VKH Syndrome -First International Workshop, 1999" was filled out by the authors, according to the information obtained from the charts.
All the patients with the diagnosis of VKH disease were included in the study.
RESULTS
Of the total of 140 patients diagnosed as having VKH disease, 18 (12.85%) fulfilled the criteria for complete disease, 41(29.28%) incomplete disease, 40 (28.57%) "probable" VKH (only ocular disease) and 40 (28.27%) were considered not having VKH disease (Figure 2 ), according to the 2001 revised diagnostic criteria ( Figure 1 ) (9) . Forty-one patients were diagnosed as having incomplete VKH disease 27 (19.28%) with neurological findings and 14 (10%) with dermatological findings (Figure 3) .
Of the 40 patients considered not having VKH, the disease was unilateral in 4 patients (2.85%), previous ocular trauma (surgical or not) was present in 3 patients (2.14%), presence of another ocular or systemic disease in 5 patients (3.58%), fundoscopy examination was impossible, due to posterior synechiae in 22 patients (15.71%) and 7 patients (5%) simply did not fulfill the criteria for the diagnosis of VKH disease (Figure 4 ). In Brazil, due to miscegenation it is very difficult to have a group of patients with homogeneous racial characteristics. Out of the 169 patients, 91.7% were considered as having VKH disease according to the 2 criteria, 8.3% were excluded on the basis of the revised diagnostic criteria. In conclusion, the study document shows that the revised criteria are capable to make a highly sensitive and specific VKH disease diagnosis.
In the present study, 29.9% of the patients did not fulfill the diagnosis of VKH disease due to the revised criteria. If we exclude the patients whose medical charts were incomplete, those that do not have the fundoscopy data, 16.1% of the patients did not fulfill the diagnosis of VKH disease according to the revised criteria.
In this study the accordance of the former and the new diagnosis criteria is different from that which was found in the 2 Japanese studies (10) (11) . A probable explanation for this fact could be related to the homogeneity of the groups and maybe because the Japanese studies considered different stages of the disease.
CONCLUSION
However, the authors consider that the revised diagnostic criteria have good sensitivity and specificity and are very useful and applicable to help in the diagnosis of VKH disease. Some authors studied the application of the revised diagnostic criteria in Japanese patients. Forty-nine patients were retrospectively studied considering early and late phases of the disease and a difference between the 2 phases was found. In this study 6% of the patients were considered not to have VKH disease according to the revised criteria.
In another Japanese study, Kitamura et al. compared two different criteria for VKH disease, the revised diagnostic criteria and Sugiura's diagnosis system. The authors studied 169 patients, all of them Japanese and 56% female. The group of patients was very homogeneous (11) .
12,85% preencheram os critérios para doença completa, 29,28% doença incompleta, 28,57% "provável" doença de Vogt-Koyanagi-Harada e 28,27% foram consideradas como não sendo doença de Vogt-Koyanagi-Harada. Conclusão: Os autores consideraram que o "International revised diagnostic criteria" tem boa aplicabilidade e é muito útil no diagnóstico da doença de Vogt-Koyanagi-Harada.
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